sedation
Conditions
Interventions
C: intranasal 0.9% saline 0.03ml/kg
D: intranasal dexmedetomidine2ug/kg+ 0.9% saline 0.01ml/kg
DS: intranasal dexmedetomidine 2ug/kg and sulfentanil 0.5ug/kg
Sponsors
Peking University School of Stomatology, Beijing
Eligibility
Sex/Gender
All
Age
2 Years to 9 Years
Inclusion criteria
Inclusion criteria: healthy children(ASA I~II), aged 2~9 yr
Exclusion criteria
Exclusion criteria: Children with a known allergy or hypersensitive reaction to either dexmedetomidine or sulfentanil , any nasal pathology,organ dysfunction, cardiac arrhythmia,congenital heart disease,or hemodynamic or respiratory instability, recent upper respiratory tract infections;children at risk for airway obstruction(obstructive sleep apnea or a craniofacial syndrome) or who had neurodevelopmental delay,cardiopulmonary disease,or any treatment with sedatives or anticonvulsants;and children whose parents refused to allow them to participate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The scores of separation from parents;The scores of compliance with mask; | — |
Secondary
| Measure | Time frame |
|---|---|
| The scores of postoperative agitation;Recovery conditions; | — |
Countries
China
Contacts
Public ContactLing Gao
Dept. of Anesthesiology, Peking University School of Stomatology, Beijing
Outcome results
None listed